[Ventilatory and cardiovascular effects of a new beta stimulating agent, terbutaline, administered subcutaneously in patients with bronchial obstruction].
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D013726:Terbutaline / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D014692:Ventilation-Perfusion Ratio / Q000187:drug effects
D013726:Terbutaline
Gli effetti ventilatori e cardiovascolari di un nuovo beta2 stimolante, la terbutalina, somministrato sottocute in pazienti broncoostruiti.